AHMED HUSSAIN: Open Payments
NPI 1396877767 · INVERNESS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$339 in 11 payments from 7 companies in 2025. Trend: 2023 $120 · 2024 $221 · 2025 $339
Food & beverage: $339
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $112 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $62 |
| ABBVIE INC. | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 1 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $33 |
| Luye Pharma (USA) Ltd. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: WATCHMAN FLX, CAPLYTA, VRAYLAR, ABILIFY ASIMTUFII, SPRAVATO, ERZOFRI EXTENDED-RELEASE, UZEDY.
Industry payments across IL — which companies pay providers there.
